{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:06:26Z","timestamp":1754161586100,"version":"3.41.2"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1023\/b:ddas.0000037819.31817.7c","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T21:06:10Z","timestamp":1092431170000},"page":"1244-1249","source":"Crossref","is-referenced-by-count":15,"title":["Pharmacodynamics and Pharmacokinetics of Oral Contraceptives Co-administered with Alosetron (Lotronex)"],"prefix":"10.1007","volume":"49","author":[{"given":"Kevin","family":"Koch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne","family":"Campanella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte A.","family":"Baidoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet A.","family":"Manzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa Z.","family":"Ameen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn E. E.","family":"Kersey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"9","key":"494229_CR1","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1111\/j.1572-0241.2001.04128.x","volume":"96","author":"T Lembo","year":"2001","unstructured":"Lembo T, Wright RA, Bagby B, Decker C, Gordon S, Jhingran P, Carter E: Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 96(9):2662\u20132670, 2001","journal-title":"Am J Gastroenterol"},{"key":"494229_CR2","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1001\/archinte.161.14.1733","volume":"161","author":"M Camilleri","year":"2001","unstructured":"Camilleri M, Chey W, Mayer E, et al.: A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant IBS. Arch Intern Med 161:1733\u20131740, 2001","journal-title":"Arch Intern Med"},{"key":"494229_CR3","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1046\/j.1365-2036.1999.00610.x","volume":"13","author":"M Camilleri","year":"1999","unstructured":"Camilleri M, Mayer E, Drossman D, et al.: Improvement in pain and bowel function in female irritable bowel syndrome patients with alosetron, a 5-HT3-receptor antagonist. Aliment Pharmacol Ther 13:1149\u20131151, 1999.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"494229_CR4","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1053\/gast.2002.36603","volume":"123","author":"L Chang","year":"2002","unstructured":"Chang L, Heitkemper MM: Gender differences in irritable bowel syndrome. Gastroenterology 123(5):1686\u20131701, 2002","journal-title":"Gastroenterology"},{"issue":"6","key":"494229_CR5","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1053\/gast.1997.v112.agast972120","volume":"112","author":"DA Drossman","year":"1997","unstructured":"Drossman DA, Whitehead WE, Camilleri M: Irritable bowel syndrome: A technical review for practice guideline development. Gastroenterology 112(6):2120\u20132137, 1997","journal-title":"Gastroenterology"},{"issue":"2","key":"494229_CR6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/107602960200800204","volume":"8","author":"A Girolami","year":"2002","unstructured":"Girolami A, Spiezia L, Girolami B, Vianello F: Tentative guidelines and practical suggestions to avoid venous thromboembolism during oral contraceptive therapy. Clin Appl Thromb Hemost 8(2):97\u2013102, 2002","journal-title":"Clin Appl Thromb Hemost"},{"issue":"4","key":"494229_CR7","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/00000478-199504000-00007","volume":"19","author":"DG Deana","year":"1995","unstructured":"Deana DG, Dean PJ: Reversible ischemic colitis in young women. Association with oral contraceptive use. Am J Surg Pathol 19(4):454\u2013462, 1995","journal-title":"Am J Surg Pathol"},{"key":"494229_CR8","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1111\/j.1572-0241.1998.00555.x","volume":"93","author":"DJ Mann","year":"1998","unstructured":"Mann DJ, Kessel E, Mullins D: Ischemic colitis and acquired resistance to activated protein C in a woman using oral contraceptives. Am J Gastroenterol 93:1960\u20131962, 1998","journal-title":"Am J Gastroenterol"},{"key":"494229_CR9","unstructured":"Manzo J, Simms L, Kersey KE, Koch K: Effect of alosetron on pharmacokinetis of levonorgestrel and ethinyl estradiol. AAPS Pharm Sci 4:abstr, 1999 (abstract available at http:\/\/www.aapspharmsci.org\/)"},{"key":"494229_CR10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1042\/bj2670221","volume":"267","author":"S Ball","year":"1990","unstructured":"Ball S, Forrester L, Wolf C, Back DJ: Differences in the cytochrome P-450 isoenzymes involved in the 2-hydroxylation of oestradiol and 17\u00df-ethinyloestradiol. Biochem J 267:221\u2013226, 1990","journal-title":"Biochem J"},{"key":"494229_CR11","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0026-895X(25)13356-7","volume":"33","author":"F Guengerich","year":"1988","unstructured":"Guengerich F: Oxidation of 17\u00df-ethynylestradiol by human liver cytochrome P-450. Mol Pharmacol 33:500\u2013508, 1988","journal-title":"Mol Pharmacol"},{"issue":"11","key":"494229_CR12","first-page":"28","volume":"15","author":"TL Dickey","year":"2002","unstructured":"Dickey TL: The hypercoagulable state as a risk factor for venous thromboembolism. Part 1. JAAPA 15(11):28\u201332, 35, 2002","journal-title":"Part 1. JAAPA"},{"issue":"11","key":"494229_CR13","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.5858\/2002-126-1405-EHFLAP","volume":"126","author":"WL Chandler","year":"2002","unstructured":"Chandler WL, Rodgers GM, Sprouse JT, Thompson AR: Elevated hemostatic factor levels as potential risk factors for thrombosis. Arch Pathol Lab Med 126(11):1405\u20131414, 2002","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"494229_CR14","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.5858\/2002-126-1296-DSFTIW","volume":"126","author":"BR Brenner","year":"2002","unstructured":"Brenner BR, Nowak-Gottl U, Kosch A, Manco-Johnson M, Laposata M: Diagnostic studies for thrombophilia in women on hormonal therapy and during pregnancy, and in children. Arch Pathol Lab Med 126(11):1296\u20131303, 2002","journal-title":"Arch Pathol Lab Med"},{"issue":"7369","key":"494229_CR15","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1136\/bmj.325.7369.887","volume":"325","author":"AG Turpie","year":"2002","unstructured":"Turpie AG, Chin BS, Lip GY: Venous thromboembolism: Pathophysiology, clinical features, and prevention. Bri Med J 325(7369):887\u2013890, 2002","journal-title":"Bri Med J"},{"issue":"6Pt2","key":"494229_CR16","doi-asserted-by":"crossref","first-page":"S375","DOI":"10.1016\/S0002-9378(99)70699-X","volume":"180","author":"J Rosing","year":"1999","unstructured":"Rosing J, Tans G: Effects of oral contraceptives on hemostasis and thrombosis. Am J Obstet Gynecol 180(6, Pt 2):S375\u2013S382, 1999","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"494229_CR17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0010-7824(01)00314-6","volume":"65","author":"HA van Vliet","year":"2002","unstructured":"van Vliet HA, Grimes DA, Helmerhorst FM, Schulz KF: Biphasic versus triphasic oral contraceptives for contraception. Contraception 65(5):321\u2013324, 2002","journal-title":"Contraception"},{"issue":"6","key":"494229_CR18","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1067\/mjd.2002.120448","volume":"46","author":"JS Archer","year":"2002","unstructured":"Archer JS, Archer DF: Oral contraceptive efficacy and antibiotic interaction: A myth debunked. J Am Acad Dermatol 46(6):917\u2013923, 2002","journal-title":"J Am Acad Dermatol"},{"issue":"1-2","key":"494229_CR19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/15287397709529555","volume":"3","author":"RE Ranney","year":"1977","unstructured":"Ranney RE: Comparative metabolism of 17alpha-ethynyl steroids used in oral contraceptives. J Toxicol Environ Health 3(1-2):139\u2013166, 1977","journal-title":"J Toxicol Environ Health"},{"key":"494229_CR20","unstructured":"Lobo RA: Progestogen metabolism. J ReprodMed44(Suppl 2):148\u2013152, 1999"},{"issue":"4","key":"494229_CR21","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1177\/00912700122010168","volume":"41","author":"DL D'Souza","year":"2001","unstructured":"D'Souza DL, Levasseur LM, Nezamis J, Robbins DK, Simms L, Koch KM: Effect of alosetron on the pharmacokinetics of alprazolam. J Clin Pharmacol 41(4):452\u2013454, 2001","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"494229_CR22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/00912700122010177","volume":"41","author":"DL D'Souza","year":"2001","unstructured":"D'Souza DL, Dimmitt DC, Robbins DK, Nezamis J, Simms L, Koch KM:Effect of alosetron on the pharmacokinetics of fluoxetine. J Clin Pharmacol 41(4):455\u2013458, 2001","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"494229_CR23","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1046\/j.0306-5251.2001.01477.x","volume":"52","author":"KM Koch","year":"2001","unstructured":"Koch KM, Ricci BM, Hedayetullah NS, Jewell D, Kersey KE: Effect of alosetron on theophylline pharmacokinetics. Br J Clin Pharmacol 52(5):596\u2013600, 2001","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"494229_CR24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1182\/blood.V100.3.743","volume":"100","author":"RA Ariens","year":"2002","unstructured":"Ariens RA, Lai TS, Weisel JW, Greenberg CS, Grant PJ. Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 100(3):743\u2013754, 2002","journal-title":"Blood"},{"issue":"3","key":"494229_CR25","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1572-0241.2001.03626.x","volume":"96","author":"SG Wolfe","year":"2001","unstructured":"Wolfe SG, Chey WY, Washington MK, Harding J, Heath AT, McSorley DJ: Tolerability and safety of alosetron during long-term administration in female and male irritable bowel syndrome patients. Am J Gastroenterol 96(3):803\u2013811, 2001","journal-title":"Am J Gastroenterol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:DDAS.0000037819.31817.7c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/B:DDAS.0000037819.31817.7c\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:DDAS.0000037819.31817.7c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T03:23:35Z","timestamp":1753759415000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/B:DDAS.0000037819.31817.7c"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":25,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["494229"],"URL":"https:\/\/doi.org\/10.1023\/b:ddas.0000037819.31817.7c","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}